SCHEMBL16420346

SCHEMBL16420346

Cc1cc(N2c3cc4ccccc4nc3N(C)[C@H]2C)c(C)c(N2c3cc4ccccc4nc3N(C)[C@@H]2C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.39
▸ KDM4E B2RXH2 7/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ATM Q13315 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 4/20 0.37
▸ TDP1 Q9NUW8 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ GLA P06280 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ STAT3 P40763 1/20 0.35
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ MBNL1 Q9NR56 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16420350 0.91 ALDH1A1 (0.39) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL16420365 0.89 ALDH1A1 (0.37) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL16709145 0.87 ALDH1A1 (0.38) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL17655190 0.87 ALDH1A1 (0.38) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL16422191 0.83 ALDH1A1 (0.39) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL16420356 0.82 KDM4E (0.33) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL16420349 0.80 KDM4E (0.41) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL16420358 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL16422190 0.79 KDM4E (0.34) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL17655188 0.76 MBNL1 (0.38) ALDH1A1KDM4EL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170250354-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-08-31 — — US disclosed
US-20150028290-A1 HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME UNIVERSAL DISPLAY CORPORATION (US) 2015-01-29 — — US disclosed
US-20150028290-A1 HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME UNIVERSAL DISPLAY CORPORATION (US) 2015-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250354-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBPL3, OR10J3, OSBP2 ALDH1A1 1215/4885KDM4E 3560/4885L3MBTL1 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback